Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Ticker SymbolAIMD
Company nameAinos Inc
IPO dateAug 08, 1996
CEOTsai (Chun-Hsien)
Number of employees44
Security typeOrdinary Share
Fiscal year-endAug 08
Address8880 Rio San Diego Drive, Ste. 800
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92108
Phone18588692986
Websitehttps://www.ainos.com/
Ticker SymbolAIMD
IPO dateAug 08, 1996
CEOTsai (Chun-Hsien)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data